BOGOTA, Colombia, March 18, 2025 /PRNewswire/ — More than 500 executives, doctors, and healthcare personnel from Keralty, along with Joseba Grajales, the group’s president, and his AI launch team, gathered in Bogotá to learn about and support a historic initiative that will position the group as one of the world’s leading organizations in Comprehensive and Integrated Global Health Ecosystems. This event marks the beginning of a revolution in global healthcare: K-AI (Keralty Artificial Intelligence).
K-AI (Keralty-AI) is the new global health integrated ecosystem powered by artificial intelligence (AI), created by Keralty, one of the most prominent international healthcare groups with a presence in the Americas, Europe, and Asia. This project was born with the purpose of transforming healthcare through a proactive, predictive, and personalized model that will enable early disease detection, optimize care processes, and provide patient-centered solutions.
K-AI is not just a project; it is a transformative vision that redefines the future of healthcare by placing AI at the core of health services worldwide.
K-AI seeks to revolutionize how healthcare is accessed and managed, combining clinical expertise with the power of AI to enhance decision-making, personalize treatments, and increase efficiency in healthcare delivery across all the countries where the group operates.
“With K-AI’s ecosystem, we are integrating artificial intelligence ethically and responsibly to anticipate diseases, personalize treatments, and build a more humane, efficient, and sustainable global health model. It is a commitment to transforming the lives of millions and leading the future of healthcare through innovation,” said Joseba Grajales of Keralty.
To bring this global ecosystem to life, a set of innovative tools and platforms has been developed to implement and scale AI-based solutions:
K-AI is supported by two Intelligent Global Networks—one for Partnerships and Allies and another for Knowledge—bringing together patients, professionals, researchers, insurers, educators, industry stakeholders, and supply chain partners to foster collaborative innovation and accelerate AI adoption in healthcare.
In addition to promoting global partnerships, the project reaffirms a commitment to ethics, transparency, and continuous education, ensuring that artificial intelligence is implemented responsibly, humanely, and in service of people’s well-being. This initiative aims to establish global leadership in healthcare innovation, integrating cutting-edge technology to build more accessible, sustainable, and patient-centered healthcare systems.
The model will be progressively implemented in all countries where the group operates, including Colombia, the United States, Mexico, Spain, Brazil, Peru, the Dominican Republic, the United Arab Emirates, and Saudi Arabia, among others. It will begin with pilot centers, adaptable to different local contexts and realities.
About Keralty
Keralty is a global group of private companies dedicated to keeping people healthy through a comprehensive healthcare model focused on prevention, risk identification and management, disease control, and care. Their successful healthcare model has allowed them to expand into several countries and partner locally with entities that help them understand the culture and needs of the population. As a result, this enables them to tailor their services across the entire health and wellness value chain to the specific circumstances of each region, making them unique. Keralty is currently operating in Colombia, the United States, Mexico, Brazil, Spain, Peru, Venezuela, the Dominican Republic, and Puerto Rico.
Today, around the world, millions of people trust their health and well-being to Keralty. That is why its companies collaborate with excellence, growth, commitment, and efficiency to meet the health, society, and community needs. Its greatest asset is its human talent, which reflects the company’s cultural identity through compassion, reciprocity, justice, respect, and solidarity.
SOURCE Keralty
Data suggests that single dose of RJVA-001 leads to durable metabolic improvements with low systemic…
Presented new preclinical data in non-human primates (NHP) for alpha-1 antitrypsin deficiency (AATD) and phenylketonuria…
Discover the Breakthrough Wearable Tech That’s Disrupting the Pain Relief Market – Kailo Flex Patch…
A breakthrough natural back pain relief program designed by wellness expert Emily Lark, the Back…
The Bone Density Solution Under Review: Blue Heron Health Osteoporosis Bone Health Guide by Shelly…
Natural Nerve Pain Relief Guide by Jodi Knapp Offers Holistic, Non-Pharmaceutical Approach to Peripheral Neuropathy—Emphasizing…